These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 21263229

  • 1. Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models.
    Kita Y, Okada M, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Nakatani H, Takao K, Kishigami C, Nishimatsu S, Sekine Y, Takamori Y, McMurray DN, De la Cruz EC, Tan EV, Abalos RM, Burgos JA, Saunderson P, Sakatani M.
    Hum Vaccin; 2011; 7 Suppl():108-14. PubMed ID: 21263229
    [Abstract] [Full Text] [Related]

  • 2. The study of novel DNA vaccines against tuberculosis: induction of pathogen-specific CTL in the mouse and monkey models of tuberculosis.
    Okada M, Kita Y, Nakajima T, Hashimoto S, Nakatani H, Nishimatsu S, Nishida Y, Kanamaru N, Kaneda Y, Takamori Y, McMurray D, Tan EV, Cang ML, Saunderson P, Dela Cruz EC.
    Hum Vaccin Immunother; 2013 Mar; 9(3):515-25. PubMed ID: 23249543
    [Abstract] [Full Text] [Related]

  • 3. Novel therapeutic vaccines [(HSP65 + IL-12)DNA-, granulysin- and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapy.
    Kita Y, Hashimoto S, Nakajima T, Nakatani H, Nishimatsu S, Nishida Y, Kanamaru N, Kaneda Y, Takamori Y, McMurray D, Tan EV, Cang ML, Saunderson P, Dela Cruz EC, Okada M.
    Hum Vaccin Immunother; 2013 Mar; 9(3):526-33. PubMed ID: 23249609
    [Abstract] [Full Text] [Related]

  • 4. Novel therapeutic vaccine: granulysin and new DNA vaccine against Tuberculosis.
    Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Nakatani H, Takao K, Kishigami C, Nishimatsu S, Sekine Y, Inoue Y, Matsumoto M, McMurray DN, De la Cruz EC, Tan EV, Abalos RM, Burgos JA, Saunderson P, Sakatani M.
    Hum Vaccin; 2011 Mar; 7 Suppl():60-7. PubMed ID: 21546794
    [Abstract] [Full Text] [Related]

  • 5. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 6. [Anti-tuberculosis immunity by cytotoxic T cells * granulysin and the development of novel vaccines (HSP-65 DNA+IL-12 DNA)].
    Okada M, Kita Y.
    Kekkaku; 2010 Jun; 85(6):531-8. PubMed ID: 20662249
    [Abstract] [Full Text] [Related]

  • 7. [Recent progress in mycobacteriology].
    Okada M, Kobayashi K.
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [Abstract] [Full Text] [Related]

  • 8. Novel prophylactic and therapeutic vaccine against tuberculosis.
    Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Nakatani H, Takao K, Kishigami C, Inoue Y, Matsumoto M, McMurray DN, Dela Cruz EC, Tan EV, Abalos RM, Burgos JA, Saunderson P, Sakatani M.
    Vaccine; 2009 May 26; 27(25-26):3267-70. PubMed ID: 19200841
    [Abstract] [Full Text] [Related]

  • 9. A Novel Therapeutic and Prophylactic Vaccine (HVJ-Envelope / Hsp65 DNA + IL-12 DNA) against Tuberculosis Using the Cynomolgus Monkey Model.
    Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nishida Y, Nakatani H, Takao K, Kishigami C, Nishimatsu S, Sekine Y, Inoue Y, Nagasawa T, Kaneda Y, Yoshida S, Matsumoto M, Paul S, Tan EV, Cruz ECD, N McMurray D, Sakatani M.
    Procedia Vaccinol; 2010 May 26; 2(1):34-39. PubMed ID: 32288910
    [Abstract] [Full Text] [Related]

  • 10. [The development of novel vaccines against tuberculosis].
    Okada M.
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct 26; 31(5):356-68. PubMed ID: 18974619
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of a novel vaccine (HVJ-liposome/HSP65 DNA+IL-12 DNA) against tuberculosis using the cynomolgus monkey model of TB.
    Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Fukamizu R, Tsunai Y, Inoue R, Nakatani H, Namie Y, Yamada J, Takao K, Asai R, Asaki R, Matsumoto M, McMurray DN, Dela Cruz EC, Tan EV, Abalos RM, Burgos JA, Gelber R, Sakatani M.
    Vaccine; 2007 Apr 20; 25(16):2990-3. PubMed ID: 17280753
    [Abstract] [Full Text] [Related]

  • 12. Novel prophylactic vaccine using a prime-boost method and hemagglutinating virus of Japan-envelope against tuberculosis.
    Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Nakatani H, Takao K, Kishigami C, Nishimatsu S, Sekine Y, Inoue Y, McMurray DN, Sakatani M.
    Clin Dev Immunol; 2011 Apr 20; 2011():549281. PubMed ID: 21437226
    [Abstract] [Full Text] [Related]

  • 13. A Novel Therapeutic and Prophylactic Vaccine against Tuberculosis Using the Cynomolgus Monkey Model and Mouse Model.
    Okada M, Kita Y, Nakajima T, Kanamaru N, Kaneda Y, Saunderson P, Tan EV, McMurray DN.
    Procedia Vaccinol; 2011 Apr 20; 4():42-49. PubMed ID: 32288912
    [Abstract] [Full Text] [Related]

  • 14. Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model.
    Kita Y, Tanaka T, Yoshida S, Ohara N, Kaneda Y, Kuwayama S, Muraki Y, Kanamaru N, Hashimoto S, Takai H, Okada C, Fukunaga Y, Sakaguchi Y, Furukawa I, Yamada K, Inoue Y, Takemoto Y, Naito M, Yamada T, Matsumoto M, McMurray DN, Cruz EC, Tan EV, Abalos RM, Burgos JA, Gelber R, Skeiky Y, Reed S, Sakatani M, Okada M.
    Vaccine; 2005 Mar 18; 23(17-18):2132-5. PubMed ID: 15755583
    [Abstract] [Full Text] [Related]

  • 15. DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation.
    Yoshida S, Tanaka T, Kita Y, Kuwayama S, Kanamaru N, Muraki Y, Hashimoto S, Inoue Y, Sakatani M, Kobayashi E, Kaneda Y, Okada M.
    Vaccine; 2006 Feb 20; 24(8):1191-204. PubMed ID: 16216394
    [Abstract] [Full Text] [Related]

  • 16. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep 20; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 17. DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.
    Wu M, Li M, Yue Y, Xu W.
    Microbiol Immunol; 2016 Sep 20; 60(9):634-45. PubMed ID: 27531823
    [Abstract] [Full Text] [Related]

  • 18. Preclinical study and clinical trial of a novel therapeutic vaccine against multi-drug resistant tuberculosis.
    Okada M, Kita Y, Hashimoto S, Nakatani H, Nishimastu S, Kioka Y, Takami Y.
    Hum Vaccin Immunother; 2017 Feb 20; 13(2):298-305. PubMed ID: 27960629
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S, Hai Z, Limei W, Jiaze A, Li X, Tingfen Z, Zhikai X, Yong Z.
    Tuberculosis (Edinb); 2009 Jan 20; 89(1):54-61. PubMed ID: 19056317
    [Abstract] [Full Text] [Related]

  • 20. Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?
    Khademi F, Derakhshan M, Yousefi-Avarvand A, Tafaghodi M, Soleimanpour S.
    Expert Rev Vaccines; 2018 Jan 20; 17(1):31-44. PubMed ID: 29148853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.